Breaking news from “The Pink Sheet” DAILY
Executive Summary
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including Mylan's launch of the first generic version of Johnson & Johnson's Duragesic and Lilly's withdrawal of NDA for stress urinary incontinence treatment Yentreve. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...
Visit 1 www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including Mylan's launch of the first generic version of Johnson & Johnson's Duragesic and Lilly's withdrawal of NDA for stress urinary incontinence treatment Yentreve . To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181.... |